Prognostic value of tumor-related molecular expression in gastric carcinoma

Pathology and Oncology Research

Volumn 15, Issue 4, 2009, Pages 589-596

  Zhao, Zhong Sheng ^a   Wang, Yuan Yu ^a   Ye, Zai Yuan ^a   Tao, Hou Quan ^a  

^a ZHEJIANG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Basic fibroblast growth factor; Gastric cancer; Matrix metalloproteinase 9; Molecular markers; Prognosis; Urokinase plasminogen activator

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BETA3 INTEGRIN; GELATINASE B; SCATTER FACTOR; SOMATOMEDIN B; UROKINASE;

ADULT; AGED; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; STOMACH CARCINOMA; SURVIVAL TIME;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, SIGNET RING CELL; DISEASE PROGRESSION; FEMALE; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; INSULIN-LIKE GROWTH FACTOR II; INTEGRIN BETA3; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 75049084716     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-009-9158-9     Document Type: Article

References (25)

1. M Inoue S Tsugane 2005 Epidemiology of gastric cancer in Japan Postgrad Med J 81 419 424 10.1136/pgmj.2004.029330 1:STN:280:DC%2BD2Mzkslehsg%3D%3D 15998815 (Pubitemid 41002579)
2. Z Wenhua H Fanghai 2008 Surgical therapy of gastric cancer in china Journal of Practical oncology 23 91 93
3. M Egeblad Z Werb, et al. 2002 New functions for the matrix metalloproteinases in cancer progression Nat Rev Cancer 2 161 174 10.1038/nrc745 1:CAS:528:DC%2BD38Xis1KktL8%3D 11990853
4. WS Moon HS Park KH Yu, et al. 2006 Expression of angiopoietin 1, 2 and their common receptor Tie2 in human gastric carcinoma: in implication for angiogenesis Journal of Korean Medical Science 21 272 278 10.3346/jkms.2006.21. 2.272 1:CAS:528:DC%2BD28Xltlaru7o%3D 16614513
5. M Niedergethmann R Hildenbrand B Wostbrock, et al. 2002 High expression of vascular endothelial growth factor predicts early recurrence and poor prognosis after curative resection for ductal adenocarcinoma of the pancreas Pancreas 25 122 129 10.1097/00006676-200208000-00002 12142733 (Pubitemid 34815907)
6. Y Kolev H Uetake S Iida, et al. 2007 Prognostic significance of VEGF expression in correlation with COX-2, microvessel density, and clinicopathological characteristics in human gastric carcinoma Annals of Surgical Oncology 14 2738 2747 17687613
7. K Mizokami Y Kakeji S Oda, et al. 2006 Clinicopathologic significance of hypoxia-inducible factor 1 alpha overexpression in gastric carcinomas Journal of Surgical Oncology 94 149 154 10.1002/jso.20568 1:CAS:528:DC%2BD28Xosl2isr4%3D 16847924 (Pubitemid 44267197)
8. N Weidner JP Semple WR Welch J Folkman 1991 Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma N Engl J Med 324 1 8 1:STN:280:DyaK3M%2FnsVWquw%3D%3D 1701519
9. SA Hundahl JL Phillips HR Menck 2000 The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: fifth edition American Joint Committee on cancer staging, proximal disease, and the 'different disease' hypothesis Cancer 88 921 932 10.1002/(SICI)1097- 0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S 1:STN:280: DC%2BD3c7ksFOiuw%3D%3D 10679663 (Pubitemid 30091113)
10. M Park H Park WH Kim H Cho JH Lee 2005 Presence of autocrine hepatocyte growth factor-Met signaling and its role in proliferation and migration of SNU-484 gastric cancer cell line Exp Mol Med 37 213 219 1:CAS:528: DC%2BD2MXmt1yqtbY%3D 16000876
11. M Niki H Iso Zaki M Toyoda, et al. 1999 Serum human hepatocyte growth factor is elevated in patients with metastatic gastric carcinoma Hepatogastroenterology 46 568 573 1:STN:280:DyaK1M3ksFGntQ%3D%3D 10228863
12. HK Yi PH Hwang DH Yang CW Kang DY Lee 2001 Expression of the insulin-like growth factors (IGFs) and the IGF-binding proteins (IGFBPs) in human gastric cancer cells Eur J Cancer 37 2257 2263 10.1016/S0959-8049(01)00269-6 1:CAS:528:DC%2BD3MXnslWgtbw%3D 11677116 (Pubitemid 33001298)
13. JX Niu WJ Zhang LY Ye 2007 The role of adhesion molecules, alpha v beta 3, alpha v beta 5 and their ligands in the tumor cell and endothelial cell adhesion Eur J Cancer Prev 16 517 527 10.1097/CEJ.0b013e3280145c00 1:CAS:528:DC%2BD2sXhtlKqs7nJ 18090124 (Pubitemid 350307501)
14. A Vonlaufen G Wiedle B Borisch 2001 Integrin alpha(v) beta(3) expression in colon carcinoma correlates with survival Mod Pathol 14 1126 32 10.1038/modpathol.3880447 1:STN:280:DC%2BD3Mnltlaruw%3D%3D 11706074 (Pubitemid 33063206)
15. S Zhang L Li JY Lin H Lin 2003 Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in invasiveness and metastasis of human gastric carcinoma World J Gastroenterol 9 899 904 1:CAS:528:DC%2BD3sXks1ymurY%3D 12717827
16. T Kaneko H Konno M Baba 2003 Urokinase-type plasminogen activator expression correlates with tumor angiogenesis and poor outcome in gastric cancer Cancer Sci 94 1 43 49 10.1111/j.1349-7006.2003.tb01350.x 1:CAS:528: DC%2BD3sXisFektb0%3D 12708473 (Pubitemid 36575857)
17. SF Yang YS Hsieh CL Lin 2005 Increased plasma levels of urokinase plasminogen activator and matrix metalloproteinase-9 in nonsmall cell lung cancer patients Clin Chim Acta 354 91 99 10.1016/j.cccn.2004.11.011 1:CAS:528:DC%2BD2MXhvVCltrY%3D 15748604 (Pubitemid 40320678)
18. ZL Gao C Zhang GY Du ZJ Lu 2007 Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma Hepatogastroenterology 54 1591 1595 1:CAS:528:DC%2BD2sXpsFKnsbo%3D 17708308
19. J Zhao XY Liu QY Zhang W Jiang 2005 Plasma level and prognostic significance of VEGF, bFGF and MMP-9 in patients with advanced non-small-cell lung cancer Zhonghua Zhong Liu Za Zhi 27 676 679 1:CAS:528:DC%2BD1cXhvFej 16438890
20. N Ramos-Desimone E Haha-Dantona J Siply, et al. 1999 Activation of matrix metalloproteinases 9 Via a converging plasmin/stromelysin-1 cascade enhances tumor cell invasion J Biol Chem 274 13066 13076 10.1074/jbc.274.19.13066 1:CAS:528:DyaK1MXjtFOlsrw%3D 10224058 (Pubitemid 29220428)
21. MH Kim 2003 Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases J Cell Biochem 89 529 538 10.1002/jcb.10543 1:CAS:528:DC%2BD3sXksVKktbs%3D 12761886 (Pubitemid 36648774)
22. SR Lee SZ Guo RH Scannevin 2007 Induction of matrix metalloproteinase, cytokines and chemokines in rat cortical astrocytes exposed to plasminogen activators Neurosci Lett 417 1 5 10.1016/j.neulet.2007.01.017 1:CAS:528:DC%2BD2sXjvFGquro%3D 17386975 (Pubitemid 46533879)
23. Y Zhao CE Lyons Jr A Xiao 2008 Urokinase directly activates matrix metalloproteinases-9: a potential role in glioblastoma invasion Biochem Biophys Res Commun 369 1215 1220 10.1016/j.bbrc.2008.03.038 1:CAS:528: DC%2BD1cXksVeisbs%3D 18355442
24. P Sapienza L di Marzo V Borrelli 2004 Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression Eur J Vasc Endovasc Surg 28 89 97 10.1016/j.ejvs.2004.02.022 1:STN:280:DC%2BD2c3nvVarug%3D%3D 15177237 (Pubitemid 38950144)
25. JS Rao C Gondi C Chetty 2005 Inhibition of invasion, angiogenesis, tumor growth, and metastasis by adenovirus-mediated transfer of antisense uPAR and MMP-9 in non-small cell lung cancer cells Mol Cancer Ther 4 1399 1408 10.1158/1535-7163.MCT-05-0082 1:CAS:528:DC%2BD2MXhtVKnt7nL 16170032